Laura (21) received her first dose of AstraZeneca in mid-April, with the second expected on July 10. “Now I’m a little sorry for the long queue and running forward,” she says. Laura is one of many people who went live in April to the mass vaccination center in the hope – “the sooner I start, the sooner I will be immune”. Immunity should start 22 days after the first dose of AstraZeneca Vaxzevria, which means local relief, but for the time being, Laura cannot enjoy the relief that will soon be due to her friend when traveling abroad.
He will not have to adhere to self-isolation upon return from abroad (EU, EEA, Switzerland and Great Britain). He did not rush, vaccination with Pfizer-BioNtech vaccine Comirnaty began later, but will receive a second dose this week, and there will be relief in a few more weeks. “We, the family, had an idea to go to the Tatras all summer. The whole family will be waiting for my second dose,” Laura admits. Her parents received a single dose of Johnson & Johnson vaccine.
As expected reactions after vaccination may vary, people’s perceptions of vaccination and feelings about the 9 to 12-week waiting period between the first and second doses of Vaxzevria and the relief seen vary. However, there are some questions that are important for many waiting for the second dose of AstraZeneva vaccine – will it be received on time? Namely, the media have reported that AstraZeneca’s delivery times not only abroad, but also in Latvia tend to be unpredictable and that European commision could not extend the contract with AstraZeneca for the supply of its Covid-19 vaccines, which will expire in June. So the questions are – will all the waiting people receive the second dose of AstraZeneca on time, will the vaccine be enough for everyone and, if not, if and what is Plan B?
How many doses of AstraZeneca have been used and how much more is needed, Delfi looked to the National Health Service. Health Minister Daniel Pavluts (AP) told a government meeting last week that vaccine manufacturer AstraZeneca had recently made late delivery forecasts, with only one forward delivery known, “but there is no reason to believe that supplies will not continue”. Thus, there is a plan A – relying on the receipt of an amount to cover the shortfall in the coming weeks, or a plan B – the Ministry of Health will consider providing a final vaccination with another vaccine.
There is no time, only a day
The fact that some people know the date but not the time of receiving the second dose of AstraZeneca’s Vaxvevria vaccine is also a source of confusion for people receiving Delfi.
–
